ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ: SPRY · Real-Time Price · USD
5.15
-0.09 (-1.63%)
Sep 10, 2026, 9:53 AM EDT - Market open
ARS Pharmaceuticals Market Cap
ARS Pharmaceuticals has a market cap or net worth of $511.66 million as of September 10, 2026. Its market cap has decreased by -48.59% in one year.
Market Cap
511.66M
Enterprise Value
539.41M
1-Year Change
-48.59%
Ranking
Category
Stock Price
$5.15
ChartMarket Cap Chart
Since November 9, 2022, ARS Pharmaceuticals's market cap has decreased from $568.25M to $511.66M, a decrease of -9.96%. That is a compound annual growth rate of -2.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 536.02M | -53.45% |
| Dec 31, 2025 | 1.15B | 12.32% |
| Dec 31, 2024 | 1.03B | 94.90% |
| Dec 29, 2023 | 526.06M | -34.23% |
| Dec 30, 2022 | 799.86M | 40.76% |
| Nov 9, 2022 | 568.25M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Scribe Therapeutics | 556.78M |
| Zura Bio | 547.18M |
| BridgeBio Oncology Therapeutics | 541.58M |
| Autolus Therapeutics | 540.31M |
| Eupraxia Pharmaceuticals | 529.14M |
| Artiva Biotherapeutics | 527.52M |
| Ovid Therapeutics | 527.30M |
| Prelude Therapeutics | 524.24M |